Related content

Treatment of Epstein–Barr Virus-associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: A case report and literature review

By Zhu Kanger   Chen Jie   Chen Shengting  

Hematology, Vol. 10, Iss. 5, 2005-10 ,pp. : 365-370

Maney Publishing

Access to resources Recommend Favorite

Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome

By Imashuku S.   Miyagawa A.   Chiyonobu T.   Ishida H.   Yoshihara T.   Teramura T.   Kuriyama K.   Imamura T.   Hibi S.   Morimoto A.   Todo S.  

Annals of Hematology, Vol. 81, Iss. 8, 2002-08 ,pp. : 470-473

Springer Publishing Company

Access to resources Recommend Favorite

Successful treatment of Epstein-Barr virus-associated T-Cell cutaneous lymphoma in a renal allograft recipient: case report and review of the literature

By Lye W.C.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1988-1989

Elsevier

Access to resources Recommend Favorite

Aberrant expression of NK cell receptors in Epstein-Barr virus-positive γδ T-cell lymphoproliferative disorders

By Zhang Yu   Ohyashiki Junko H.   Shimizu Norio   Ohyashiki Kazuma  

Hematology, Vol. 15, Iss. 1, 2010-02 ,pp. : 43-47

Maney Publishing

Access to resources Recommend Favorite

Lytic infection of Epstein-Barr virus (EBV) in hemophagocytic syndrome associated with EBV-induced lymphoproliferative disorder

By Yamamoto T.  

Annals of Hematology, Vol. 83, Iss. 2, 2004-02 ,pp. : 127-132

Springer Publishing Company

Access to resources Recommend Favorite